ADR News Bulletin 2023 December (Volume 25 Number 3)
20 December 2023
Audiences
Healthcare professional
Industry member
Product-type
Therapeutic Products
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Isotretinoin and risk of psychiatric disorders and sexual dysfunction
Severe cutaneous adverse reaction reports with modafinil and armodafinil
AE Case in Focus 1: Test Yourself - What could have caused the rash in this patient?
AE Case in Focus 2: Test Yourself - What was the likely cause of the musculoskeletal symptoms in this patient? What treatment options were available for his hyperlipidaemia?
HSA participated in WHO-UMC #MedSafetyWeek 2023 global social media campaign on adverse event reporting
Click on the link below to download the issue in pdf:
